U.S. Markets closed
  • S&P Futures

    4,133.50
    +5.75 (+0.14%)
     
  • Dow Futures

    33,753.00
    +44.00 (+0.13%)
     
  • Nasdaq Futures

    13,768.25
    +18.00 (+0.13%)
     
  • Russell 2000 Futures

    2,240.10
    +11.80 (+0.53%)
     
  • Crude Oil

    61.75
    +0.32 (+0.52%)
     
  • Gold

    1,784.70
    +2.70 (+0.15%)
     
  • Silver

    26.17
    -0.01 (-0.04%)
     
  • EUR/USD

    1.2026
    +0.0009 (+0.0722%)
     
  • 10-Yr Bond

    1.5540
    -0.0100 (-0.64%)
     
  • Vix

    18.71
    +1.21 (+6.91%)
     
  • GBP/USD

    1.3838
    -0.0005 (-0.0360%)
     
  • USD/JPY

    107.9030
    -0.0570 (-0.0528%)
     
  • BTC-USD

    51,843.36
    -2,346.42 (-4.33%)
     
  • CMC Crypto 200

    1,197.79
    -45.27 (-3.64%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • Nikkei 225

    28,863.72
    -324.45 (-1.11%)
     

Top Stock Reports for Johnson & Johnson, UnitedHealth & Comcast

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Mark Vickery
·6 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Tuesday, March 2, 2021

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), UnitedHealth Group (UNH) and Comcast (CMCSA). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Johnson & Johnson shares have outperformed the Zacks Large-Cap Pharmaceuticals industry over the past year (+17.5% vs. +10.3%). The Zacks analyst believes that J&J’s diversification makes it relatively resilient amid the macroeconomic turmoil.

The Pharma unit is performing at above-market levels, supported by successful label expansion of blockbuster drugs, Imbruvica, Darzalex and Stelara. Meanwhile, its Consumer Health unit also performed above-market in 2020 while the Medical Devices segment demonstrated a strong second-half recovery.

J&J is also making rapid progress with its pipeline and line extensions. Several pivotal data readouts are expected in 2021. However, headwinds like generic competition and pricing pressure continue.

(You can read the full research report on Johnson & Johnson here >>>)

Shares of UnitedHealth have gained 5.9% in the last six months against the Zacks Medical Insurance industry’s gain of 5.3%. The Zacks analyst believes that the company remains well poised to gain from its government business, comprising both Medicaid and Medicare Advantage.

The company’s top line is bolstered by new deals, renewed agreements and expansion of service offerings. Its numerous acquisitions bode well for its inorganic growth profile. Its solid health services segment provides significant diversification benefits.

Moreover, a sturdy balance sheet and consistent cash flow generation is another positive, which has resulted in a solid capital position. This has empowered the company to engage in prudent shareholder-friendly moves through share buybacks and dividend payments.

(You can read the full research report on UnitedHealth here >>>)

Comcast’s shares have gained 5.6% over the past three months against the Zacks Cable Television industry’s loss of 0.6%. The Zacks analyst believes that Comcast is benefiting from solid high-speed Internet customer wins.

Its strategy to provide high-speed Internet at an affordable price plays a pivotal role in providing connectivity and improving customer experience. Moreover, coronavirus-led increased media consumption, and work-from-home and online-learning waves bode well for Comcast’s Internet business.

Its streaming service, Peacock, has gained significant tract within a short span of time and is a key catalyst in driving broadband sales. However, Comcast persistently suffers from video-subscriber attrition due to cord cutting. Also, theme park revenues are expected to suffer from lower footfall and the indefinite closure of Hollywood Park. 

(You can read the full research report on Comcast here >>>)

Other noteworthy reports we are featuring today include QUALCOMM (QCOM), AstraZeneca (AZN) and Micron Technology (MU).

Zacks Top 10 Stocks for 2021

In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?

Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

AccessZacks Top 10 Stocks for 2021 today >>

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

J&J's (JNJ) Pharma Segment Resilient Amid Generic Headwinds

Solid Top Line, Strong Balance Sheet Aid UnitedHealth (UNH)

High Speed Internet Subscriber Gain Benefits Comcast (CMCSA)

Featured Reports

Qualcomm (QCOM) Rides on Novel Chip Designs for 5G Traction

Per the Zacks analyst, Qualcomm is well poised to gain from solid 5G traction with more than 700 5G designs and innovative product launches.

Cancer Drugs Push AstraZeneca's (AZN) Sales, Pipeline Solid

The Zacks analyst says that AstraZeneca's cancer drugs, Lynparza, Tagrisso and Imfinzi, should keep driving revenues.

Micron (MU) Benefits from Growing Memory-Chip Demand

Per the Zacks analyst, Micron is riding on solid memory-chip demand from cloud-computing providers and acceleration in 5G adoptions.

Tower Buyouts Aid American Tower (AMT), Churn Woes Linger

Per the Zacks analyst, tower buyouts in new global markets aid American Tower to gain on high carrier network spending.

Robust Demand Aids Lockheed (LMT), F-35 program's Cost Hurts

Per the Zacks analyst, Lockheed Martin witnesses strong demand for its aircraft programs and missile defense systems.

Digital Investments Likely to Aid lululemon's (LULU) Sales

Per the Zacks analyst, lululemon is heavily investing in e-commerce capabilities like developing sites, transactional omni-functionality and fulfillment options to capture the robust online demand.

Cheniere's (CQP) Profits to Rise on Lower Feedstock Costs

The Zacks analyst expects Cheniere Partners' bottom line to get a boost from lower pricing of natural gas feedstock.

New Upgrades

Acquisitions, Strong Cash Flows Drive Select Medical (SEM)

Per the Zacks analyst, numerous buyouts have resulted in a geographically diversified portfolio and strengthened U.S. footprint for the company. Also, strong cash flows enable investment in business.

Residential Demand, Inorganic Moves Aid UFP Industries (UFPI)

Per the Zacks analyst, UFP Industries has been benefiting from robust demand in the U.S. residential market. Also, its acquisition strategies for solidifying product portfolio bode well.

Rent-A-Center's (RCII) E-commerce Business Exhibits Strength

Per the Zacks analyst, Rent-A-Center is focused on increasing omni-channel sales, leveraging store infrastructure and driving e-commerce growth.

New Downgrades

Donaldson's (DCI) Growth Marred by Weak Gas Turbine Market

Per the Zacks analyst, prolonged weakness in the gas turbine market will continue to hurt Donaldson's sales. Further, weakness in the industrial filtration solutions market remains a concern.

Colorado Regulatory Landscape to Weigh on PDC Energy (PDCE)

The Zacks analyst believes that Colorado's new oil and gas drilling rules will be a real concern for local operators like PDC Energy, exposing it to an element of uncertainty.

Weak Demand & High Input Costs to Weigh on Terex (TEX)

The Zacks analyst is concerned that delayed capital purchases owing to cautious customer sentiment amid the pandemic as well as high steel costs will weigh on Terex's results.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report
 
Micron Technology, Inc. (MU) : Free Stock Analysis Report
 
Comcast Corporation (CMCSA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research